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CC BY-NC-ND license (http://creatiSummary Background: Breast conserving surgery (BCS) is preferred for suitable candidates,
while mastectomy (MTX) with reconstruction (MTX þ R) is considered a better option for pa-
tients requiring MTX. In Hong Kong, the rates of BCS and breast reconstruction are relatively
low. This paper aims to study the surgical options and their predictors among Hong Kong breast
cancer patients.
Methods: Data is retrieved from the Hong Kong Breast Cancer Registry (HKBCR) from 2007 to
2013. A total of 4519 Stage IeII breast cancer patients who had surgical treatments were
included in this retrospective study.
Results: Our multivariate logistic regression shows that people who were younger
(age < 40 years: OR, 1.5; 95% CI, 1.1e2.1; p Z 0.010), more educated (undergraduate/post-
graduate: OR, 2.8; 95% CI, 1.7e4.4; p < 0.0001), never married (OR, 1.5; 95% CI, 1.1e1.9;
p Z 0.002), had regular mammography screening (OR, 1.5; 95% CI, 1.3e1.8; p < 0.0001),
had screen-detected cancers (OR, 1.3; 95% CI, 1.0e1.6; p Z 0.031), and who underwent sur-
gery at a private medical service facility (OR, 1.8; 95% CI, 1.6e2.2; p < 0.0001) were more
likely to receive BCS. In addition, people who were younger (age < 40 years: OR, 15.9; 95%
CI, 6.5e39.2; p < 0.0001), more educated (undergraduate/postgraduate: OR, 26.8; 95% CI,
3.6e201.4; p Z 0.001), had regular mammography screening (OR, 1.6; 95% CI, 1.1e2.3;
pZ 0.008), had screen-detected cancers (OR, 2.1; 95% CI, 1.4e3.3; pZ 0.001), and had smal-
ler tumor ( 2.0 cm: OR, 0.39; 95% CI, 0.20e0.76; pZ 0.005) were more likely to have recon-
struction after MTX.ng authors declare no conflicts of interest.
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Hong Kong Breast Cancer Registry, AConclusion: Chinese patients have lower BCS and breast reconstruction rate. Besides cultural
difference, patient-related factors such as age, education, marital status, mammography
screening, the use of private medical facilities, and clinical characteristics including smaller
tumor size and peripherally located tumor were significant predictors for type of surgical treat-
ments in Chinese women with early breast cancer.
Copyright ª 2016, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Over the last decade, breast cancer surgeries have evolved
from radical mastectomy (MTX) to less aggressive surgical
options. The development of breast conservation therapy
has allowed doctors to have better control of the treatment
process and improved cosmetic outcomes. A number of
randomized trials have shown that breast conserving sur-
gery (BCS) and modified radical MTX for women with early-
stage breast cancer yield equal surgical outcomes.1e5
Indeed, the National Institutes of Health in the US has
recommended breast conservation therapy as an appro-
priate method of primary therapy for women with early-
stage breast cancer.6 In the 21st century, multidisciplinary
management and personalized therapy of breast cancer
emphasized both the survival outcome and the importance
of functional recovery, with the ability to preserve and
restore body shape and function, as well as psychosocial
recovery and quality of life becoming an integral part of
breast cancer management. Oncoplastic breast surgeries
offering different reconstructive options have become
important in modern breast cancer management.
Despite the availability of different surgical options for
women with early-stage breast cancer, there are large
geographical differences and institutional variations in the
rates of breast conservation therapy and breast recon-
structive surgeries.7 According to the Hong Kong Hospital
Authority’s “6th Report of the Surgical Outcome Monitoring
and Improvement Program”, the rates of BCS and breast
reconstruction in Hong Kong were 22.9% and 11%, respec-
tively, among patients who had undergone MTX.8 These
rates are low compared to other countries. Meanwhile,
studies in other countries have shown that surgical options
for breast cancer are associated with age, education,
ethnic groups, involvement of patients in decision making,
and clinical pathological factors.9e12 In a similar vein, we
conducted a retrospective study using data extracted from
the Hong Kong Breast Cancer Registry (HKBCR) to study the
choices of surgical treatment in Hong Kong and to explore
the influence of patient-related factors including age and
level of education, clinical characteristics such as tumor
size and medical service facilities factors on surgical
choices for breast cancer treatment.2. Methods
The HKBCR is the most comprehensive and representative
registry on breast cancer in Hong Kong. The population-
wide registry, established in 2007 by Hong Kong Breastan SWW, et al., Surgical options fo
sian Journal of Surgery (2016), htCancer Foundation (HKBCF), collects over 300 data items
from each local breast cancer case, including risk expo-
sures, treatments, clinical outcomes, and survival rates.
The research and the analyses give patients, medical pro-
fessionals, and policy makers a better understanding of
breast cancer in Hong Kong and help to improve the pre-
vention, detection, and treatment of breast cancer as well
as care for patients.
From 2007 to 2013, as many as 6278 breast cancer pa-
tients had given their consent to be registered with the
HKBCR. Our retrospective observation study examined the
data of 4519 of these patients who were diagnosed with
invasive breast cancer Stage IeII and who had surgical
treatments for breast cancer. Data on patient factors such
as demographics, clinical pathologic variables, and the use
of public medical service facilities were extracted from the
HKBCR and analyzed retrospectively.
The relationship between surgical treatments for breast
cancer and patient characteristics, sociodemographic data,
screening habits, clinical and pathologic variables, and
medical service facilities factors were examined using
univariate analysis. Binary logistics regression was
employed to construct a predictive model to explain what
factors had effects on outcome of BCS with reference to all
MTX or what factor influenced the outcome of MTX with
reconstruction (MTX þ R) with reference to MTX alone. In
univariate analysis, explanatory variables with p < 0.1 were
included in the final multivariable analysis with backward
stepwise regression. The explanatory variables in the final
model with p < 0.05 were considered as significant pre-
dictors. All statistical analyses were performed by SPSS
software version 18.0 (SPSS Inc., Chicago, IL, USA).3. Results
A total of 4620 tumors were reported in the 4519 breast
cancer patients we examined retrospectively, with 43.2%
and 56.8% of the tumors diagnosed as Stage I and Stage II
invasive breast cancer, respectively. Among the patients,
40.5% of them underwent BCS, 51.5% had MTX, and 8.0%
underwent MTX þ R. The laterality of tumors was similar in
both breasts: 2274 (49.2%) patients had cancer in their left
breasts, 2188 (47.4%) in their right breasts, and 79 (1.7%)
had bilateral breast cancers.
3.1. Patient characteristics
The mean ages of patients who underwent BCS, MTX, and
MTX þ R were 48.4 years, 52.6 years, and 44.4 years,r Chinese patients with early invasive breast cancer: Data from the
tp://dx.doi.org/10.1016/j.asjsur.2016.02.003










< 40 271 (14.7%) 175 (7.6%) 88 (24.4%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R,
p < 0.00140e49 769 (41.6%) 791 (34.2%) 178 (49.4%)
50e59 526 (28.4%) 794 (34.4%) 67 (18.6%)
 60 198 (10.7%) 500 (21.6%) 9 (2.5%)
Unknown 85 (4.6%) 50 (2.2%) 18 (5.0%)
Education level
No schooling/kindergarten 37 (2.0%) 171 (7.4%) 1 (0.3%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R,
p < 0.001Primary school 289 (15.6%) 717 (31.0%) 32 (8.9%)
Secondary school 942 (50.9%) 1072 (46.4%) 169 (46.9%)
Matriculation 160 (8.7%) 108 (4.7%) 43 (11.9%)
Undergraduate/
postgraduate
316 (17.1%) 156 (6.8%) 99 (27.5%)
Unknown 105 (5.7%) 86 (3.7%) 16 (4.4%)
Occupation
Professional/clerical 723 (39.1%) 502 (21.7%) 180 (50.0%) BCS vs. MTX, p < 0.001
Non-clerical/labor 268 (14.5%) 591 (25.6%) 56 (15.6%) MTX vs. MTX þ R, p < 0.001
Housewife 518 (28.0%) 825 (35.7%) 66 (18.3%)
Self-employed 66 (3.6%) 57 (2.5%) 15 (4.2%)
Retired/unemployed 135 (7.3%) 229 (9.9%) 14 (3.9%)
Unknown 139 (7.5%) 106 (4.6%) 29 (8.1%)
Marital status
Never married 274 (14.8%) 206 (8.9%) 60 (16.7%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R, p <
0.001Married 1338 (72.4%) 1824 (79.0%) 252 (70.0%)
Widowed/divorced/
cohabitating
156 (8.4%) 225 (9.7%) 32 (8.9%)
Unknown 81 (4.4%) 55 (2.4%) 16 (4.4%)
Smoking before BC diagnosis
No 1683 (91.0%) 2143 (92.8%) 328 (91.1%) NS
Yes 80 (4.3%) 94 (4.1%) 17 (4.7%)
Unknown 86 (4.7%) 73 (3.2%) 15 (4.2%)
Previous breast diseases
No 1481 (80.1%) 1942 (84.1%) 289 (80.3%) NS
Yes 253 (13.7%) 299 (12.9%) 52 (14.4%)
Unknown 115 (6.2%) 69 (3.0%) 19 (5.3%)
Self-reported significant past health
Good 1208 (65.3%) 1593 (69.0%) 257 (71.4%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R,
p < 0.001Minor 424 (22.9%) 427 (18.5%) 68 (18.9%)
Major 91 (4.9%) 185 (8.0%) 4 (1.1%)
Unknown 126 (6.8%) 105 (4.5%) 31 (8.6%)
Reproductive history
No 372 (20.1%) 320 (13.9%) 86 (23.9%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R,
p < 0.001Yes 1258 (68.0%) 1857 (80.4%) 230 (63.9%)
Unknown 219 (11.8%) 133 (5.8%) 44 (12.2%)
Breast self-examination
Never 554 (30.0%) 1006 (43.5%) 89 (24.7%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R,
p < 0.001Occasional 719 (38.9%) 734 (31.8%) 174 (48.3%)
Regular 440 (23.8%) 473 (20.5%) 75 (20.8%)
Unknown 136 (7.4%) 97 (4.2%) 22 (6.1%)
Clinical breast examination
Never 565 (30.6%) 1184 (51.3%) 99 (27.5%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R,
p < 0.001Occasional 240 (13.0%) 230 (10.0%) 45 (12.5%)
Regular 911 (49.3%) 805 (34.8%) 196 (54.4%)
Unknown 133 (7.2%) 91 (3.9%) 20 (5.6%)
(continued on next page)
Surgical options for early breast cancer patients 3
+ MODEL
Please cite this article in press as: Chan SWW, et al., Surgical options for Chinese patients with early invasive breast cancer: Data from the
Hong Kong Breast Cancer Registry, Asian Journal of Surgery (2016), http://dx.doi.org/10.1016/j.asjsur.2016.02.003









Never 985 (53.3%) 1666 (72.1%) 197 (54.7%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R,
p < 0.001Occasional 193 (10.4%) 171 (7.4%) 35 (9.7%)
Regular 530 (28.7%) 372 (16.1%) 106 (29.4%)
Unknown 141 (7.6%) 101 (4.4%) 22 (6.1%)
Average monthly household income
< HK$10,000 182 (9.8%) 345 (14.9%) 23 (6.4%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R,
p < 0.001HK$10,000e29,999 496 (26.8%) 613 (26.5%) 89 (24.7%)
 HK$30,000 543 (29.4%) 293 (12.7%) 141 (39.2%)
Unknown 628 (34.0%) 1059 (45.8%) 107 (29.7%)
BC Z breast cancer; BCS Z breast conserving treatment; MTX Z mastectomy alone; MTX þ RZ mastectomy with reconstruction; NS:
non-significance.
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significantly younger than those who had MTX. Compared
with the patients who only had MTX, those who underwent
BCS or MTX þ R had a higher level of education (BCS 17.1%
and MTX þ R 27.5% vs. MTX 6.8%; all p < 0.001). Patients
who had BCS or MTX þ R were also more likely to have a
professional occupation than patients with MTX (BCS 39.1%
and MTX þ R 50.0% vs. MTX 21.7%; all p < 0.001). The
percentage of patients who were never married was higher
in the BCS or MTX þ R group than the MTX group (BCS 14.8%
and MTX þ R 16.7% vs. MTX 8.9%; all p < 0.001). The BCS or
MTX þ R group also had a higher household income than the
MTX group (BCS 29.4% and MTX þ R 39.2% vs. MTX 12.7%; all
p < 0.001) (Table 1).3.2. Clinical characteristics
Table 2 presents the clinical and pathological characteris-
tics by type of surgical treatments. Patients who had BCS
were more likely to have smaller tumors than those who
had MTX (62.6% vs. 43.7%, p < 0.001). However, the pa-
tients who underwent MTX þ R were more likely to have
larger tumors than the MTX group (7.8% vs. 2.6%,
p < 0.001). The location of the breast tumor has been found
to be significantly associated with the type of surgical
treatments. The BCS group had fewer central breast tumors
than the MTX group (3.7% vs. 6.8%, p < 0.001), while the
percentage of central breast tumors was significantly
higher in the MTX þ R group compared to the MTX group
(15.6% vs. 6.8%, p < 0.001). Patients who underwent BCS
had fewer multifocal and multicentric breast tumors than
those who had MTX (all p < 0.001). By contrast, patients
who underwent MTX þ R had more multifocal and multi-
centric breast tumors than the MTX group (all p < 0.001).
Significantly more patients in the BCS group had estrogen
receptor (ER) positive or progesterone receptor (PR) posi-
tive cancers than in the MTX group, and significantly fewer
patients in the BCS group were c-erbB2 positive than in the
MTX group (all p < 0.001). These differences were absent
between the MTX group and the MTX þ R group.Please cite this article in press as: Chan SWW, et al., Surgical options fo
Hong Kong Breast Cancer Registry, Asian Journal of Surgery (2016), ht3.3. Breast screening habits
The percentage of patients who had regular mammography
screening was higher in the BCS group than in the MTX group
(28.7% vs. 16.1%, p < 0.001). This observation was also
found in the MTX þ R group when compared with the MTX
group (29.4% vs. 16.1%, p < 0.001) (Table 1).
3.4. Surgical treatment at private and public
medical facilities
Of the 4620 invasive breast tumor cases, 2825 (61.1%) were
treated surgically in a private medical facility, and the rest,
1795 (38.9%), in a public medical facility. Patients who had
BCS were more likely to receive surgical treatment in a
private medical facility compared with those who under-
went MTX (73.4% vs. 50.5%, p < 0.001). Patients who had
MTX þ R were also more likely to opt for a private hospital
than the MTX group (67.1% vs. 50.5%, p < 0.001) (Table 2).
3.5. Factors associated with BCS vs. MTX
Using multivariate logistic regression, significant predictive
factors for BCS included younger age (age < 40 years: OR,
1.5; 95% CI, 1.1e2.1; pZ 0.010; age 40e49 years: OR, 1.6;
95% CI, 1.2e2.0; p < 0.0001), higher education level (sec-
ondary school: OR, 2.2; 95% CI, 1.4e3.3; p < 0.0001;
matriculation: OR, 2.6; 95% CI, 1.5e4.2; p < 0.0001; un-
dergraduate/postgraduate: OR, 2.8; 95% CI, 1.7e4.4;
p < 0.0001), never married (OR, 1.5; 95% CI, 1.1e1.9;
p Z 0.002), minor significant past health (OR, 1.2; 95% CI,
1.0e1.5; p Z 0.019), regular mammography screening
(occasional screening: OR, 1.5; 95% CI, 1.2e1.9; pZ 0.001;
regular screening: OR, 1.5; 95% CI, 1.3e1.8; p < 0.0001),
method of first detection (screen-detected: OR, 1.3; 95%
CI, 1.0e1.6; p Z 0.031), smaller tumor size (tumor
size  2.0 cm: OR, 13.4; 95% CI, 6.0e30.1; p < 0.0001;
tumor size 2.01e5.0 cm: OR, 6.2; 95% CI, 2.8e14.0;
p < 0.0001), tumor in the central region (OR, 0.43; 95% CI,
0.31e0.61; p < 0.0001), and private medical service facility
(OR, 1.8; 95% CI, 1.6e2.2; p < 0.0001) (Table 3).r Chinese patients with early invasive breast cancer: Data from the
tp://dx.doi.org/10.1016/j.asjsur.2016.02.003
Table 2 Clinical characteristics in patients undergoing breast conserving surgery, mastectomy and mastectomy with
reconstruction.
BCS (nZ 1871) MTX (nZ 2378) MTX þ R (nZ 371) p
Surgery in medical facility
Private hospital 1374 (73.4%) 1202 (50.5%) 249 (67.1%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R, p < 0.001
Public hospital 497 (26.6%) 1176 (49.5%) 122 (32.9%)
Method of first detection
Accidental
discovery
1473 (78.7%) 1950 (82.0%) 289 (77.9%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R, p < 0.001
Screen-detected 247 (13.2%) 158 (6.6%) 48 (12.9%)
Unknown 151 (8.1%) 270 (11.4%) 34 (9.2%)
Largest tumor size (cm)a
 2.00 1171 (62.6%) 1039 (43.7%) 111 (29.9%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R, p < 0.001
2.01e5.00 658 (35.2%) 1206 (50.7%) 217 (58.5%)
> 5.00 12 (0.6%) 61 (2.6%) 29 (7.8%)
Unknown 30 (1.6%) 72 (3.0%) 14 (3.8%)
Upper outer quadrant (UOQ)
No 994 (53.1%) 1254 (52.7%) 215 (58.0%) NS
Yes 877 (46.9%) 1124 (47.3%) 156 (42.0%)
Upper inner quadrant (UIQ)
No 1458 (77.9%) 1934 (81.3%) 293 (79.0%) BCS vs. MTX, p Z 0.006; MTX vs. MTX þ R, NS
Yes 413 (22.1%) 444 (18.7%) 78 (21.0%)
Lower outer quadrant (LOQ)
No 1605 (85.8%) 2035 (85.6%) 325 (87.6%) NS
Yes 266 (14.2%) 343 (14.4%) 46 (12.4%)
Lower inner quadrant (LIQ)
No 1696 (90.6%) 2181 (91.7%) 335 (90.3%) NS
Yes 175 (9.4%) 197 (8.3%) 36 (9.7%)
Central
No 1801 (96.3%) 2217 (93.2%) 313 (84.4%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R, p < 0.001
Yes 70 (3.7%) 161 (6.8%) 58 (15.6%)
Multifocality
No 1085 (58.0%) 1172 (49.3%) 175 (47.2%) BCS vs. MTX, p < 0.001
Yes 148 (7.9%) 313 (13.2%) 110 (29.7%) MTX vs. MTX þ R, p < 0.001
Unknown 638 (34.1%) 893 (37.5%) 86 (23.2%)
Multicentricity
No 1202 (64.2%) 1349 (56.7%) 229 (61.7%) BCS vs. MTX, p < 0.001
Yes 11 (0.6%) 78 (3.3%) 42 (11.3%) MTX vs. MTX þ R, p < 0.001
Unknown 658 (35.2%) 951 (40.0%) 100 (27.0%)
ER positive
No 367 (19.6%) 596 (25.1%) 92 (24.8%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R, NS
Yes 1458 (77.9%) 1708 (71.8%) 261 (70.4%)
Unknown 46 (2.5%) 74 (3.1%) 18 (4.9%)
PR positive
No 591 (31.6%) 846 (35.6%) 146 (39.4%) BCS vs. MTX, p Z 0.002; MTX vs. MTX þ R, NS
Yes 1232 (65.8%) 1443 (60.7%) 204 (55.0%)
Unknown 48 (2.6%) 89 (3.7%) 21 (5.7%)
cerbB positive
No 1206 (64.5%) 1265 (53.2%) 194 (52.3%) BCS vs. MTX, p < 0.001; MTX vs. MTX þ R, NS
Yes 307 (16.4%) 528 (22.2%) 103 (27.8%)
Unknown 358 (19.1%) 585 (24.6%) 74 (19.9%)
BCS Z breast conserving treatment; MTXZ mastectomy alone; MTX þ RZ mastectomy with reconstruction; ERZ estrogen receptor;
PR Z progesterone receptor; NS Z non-significance.
a Largest tumor size is used for analysis if there is more than one tumor in the same breast.
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Table 3 shows that significant explanatory factors for
MTX þ R in the multivariate logistic regression modelPlease cite this article in press as: Chan SWW, et al., Surgical options fo
Hong Kong Breast Cancer Registry, Asian Journal of Surgery (2016), htincluded younger age (age < 40 years: OR, 15.9; 95% CI,
6.5e39.2; p < 0.0001; age 40e49: OR, 9.3; 95% CI,
3.9e21.8; p < 0.0001; age 50e59 years: OR, 4.2; 95% CI,
1.8e10.1; p Z 0.001), higher education level (secondaryr Chinese patients with early invasive breast cancer: Data from the
tp://dx.doi.org/10.1016/j.asjsur.2016.02.003
Table 3 Multivariate regression on likelihood of breast surgery for invasive breast cancer cases.
BCS
(all MTX: reference)
p MTX þ R
(MTX: reference)
p
Adjusted OR (95% CI) Adjusted OR (95% CI)
Age group Reference: > 60 y.o.
< 40 1.5 (1.1e2.1) 0.010 15.9 (6.5e39.2) < 0.0001
40e49 1.6 (1.2e2.0) < 0.0001 9.3 (3.9e21.8) < 0.0001
50e59 1.2 (0.97e1.6) 0.082 4.2 (1.8e10.1) 0.001
Education level Reference: no schooling/kindergarten
Primary school 1.5 (0.98e2.3) 0.060 4.1 (0.54e30.8) 0.174
Secondary school 2.2 (1.4e3.3) < 0.0001 8.5 (1.2e62.9) 0.035
Matriculation 2.6 (1.5e4.2) < 0.0001 17.7 (2.3e136.2) 0.006
Undergraduate/postgraduate 2.8 (1.7e4.4) < 0.0001 26.8 (3.6e201.4) 0.001
Marital status Reference: married
Never married 1.5 (1.1e1.9) 0.002 1.1 (0.72e1.7) 0.618
Divorced/separated/cohabitating 1.1 (0.88e1.5) 0.339 1.9 (1.2e3.1) 0.010
Self-reported significant past health Reference: good
Minor 1.2 (1.0e1.5) 0.019 1.0 (0.72e1.5) 0.837
Major 1.0 (0.77e1.4) 0.801 0.22 (0.07e0.71) 0.011
Screening mammography Reference: never
Occasional 1.5 (1.2e1.9) 0.001 1.4 (0.84e2.3) 0.207
Regular 1.5 (1.3e1.8) < 0.0001 1.6 (1.1e2.3) 0.008
Method of first detection Reference: accidental discovery
Screen-detected 1.3 (1.0e1.6) 0.031 2.1 (1.4e3.3) 0.001
Largest tumor size (cm) Reference: > 5.00 cm
 2.0 13.4 (6.0e30.1) < 0.0001 0.39 (0.20e0.76) 0.005
2.01-5.00 6.2 (2.8e14.0) < 0.0001 0.69 (0.36e1.3) 0.258
Tumor at central region 0.43 (0.31e0.61) < 0.0001 2.2 (1.4e3.4) 0.001
Surgical operation location Reference: public hospital
Private hospital 1.8 (1.6e2.2) < 0.0001 ee
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tion: OR, 17.7; 95% CI, 2.3e136.2; p Z 0.006; undergrad-
uate/postgraduate: OR, 26.8; 95% CI, 3.6e201.4;
p Z 0.001), having divorced (OR, 1.9; 95% CI, 1.2e3.1;
pZ 0.010), major significant past health (OR, 0.22; 95% CI,
0.07e0.71; p Z 0.011), regular mammography screening
(OR, 1.6; 95% CI, 1.1e2.3; p Z 0.008), method of first
detection (screen-detected: OR, 2.1; 95% CI, 1.4e3.3;
p Z 0.001), smaller tumor size (tumor size  2.0 cm: OR,
0.39; 95% CI, 0.20e0.76; p Z 0.005), and tumor at central
region (OR, 2.2; 95% CI, 1.4e3.4; p Z 0.001) (Table 3).
Receiver operating characteristic curves were con-
structed to indicate how well the prediction models for BCS
and breast reconstruction were. Area under the curve
(AUC) ranging from 0.7 to 0.8 was considered as fair, while
one ranging from 0.8 to 0.9 was deemed as good. Figures 1A
and 1B showed that AUCs were 0.711 for BCS and 0.818 for
MTX þ R, indicating that the models produced fairly good
predictions for the outcomes of interest.4. Discussion
In Hong Kong, the incidence of breast cancers has increased
over time, with the latest reported incidence being over
3500 cases in 2012, indicating an increasing need for sur-
gical treatment for breast cancer patients.13 ComparedPlease cite this article in press as: Chan SWW, et al., Surgical options fo
Hong Kong Breast Cancer Registry, Asian Journal of Surgery (2016), htwith other countries, Hong Kong has a lower rate of BCS and
reconstructive surgery. The difference may be attributable
to cultural difference14 or patient-related factors.15e17
Our study shows that 40.5% of Chinese women patients
have had BCS, which is higher than what was reported in
Hong Kong Hospital Authority’s Surgical Outcome Moni-
toring and Improvement Program (SOMIP).8 The main
reason for the difference is SOMIP only included patients
from public hospitals, which have a lower rate of BCS.
However, our study reports that 8.0% underwent MTX þ R
and the rate is low when compared to western countries,
where the rate of BCS was 61.4% and the rate of MTX þ R
was 70%.18,19 Asian/Pacific Islanders were more likely to
undergo MTX18 and Asian and black women were less likely
to undergo MTX þ R as compared to white women.19 This
might be attributed to a generally more conservative atti-
tude of Chinese patients. According to our findings, younger
women and/or those who have a higher education level or
who are more knowledgeable were more likely to have BCS
and breast reconstruction. The results were in agreement
with previous studies.20e24 It is possible that patients who
are more educated feel more empowered to be involved in
choosing the type of surgical treatment they are to un-
dergo. Healthcare professionals and patients should note
that patient education on BCS and breast reconstruction
can influence the surgical option. While marital status was
not a significant predictor for breast conserving treatmentr Chinese patients with early invasive breast cancer: Data from the
tp://dx.doi.org/10.1016/j.asjsur.2016.02.003
Figure 1 (A) Receiver operating characteristic (ROC) curve
for breast conserving surgery (AUCZ 0.711), (B) ROC curve for
mastectomy with reconstruction (AUC Z 0.818).
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+ MODELin previous studies,9,24,25, our study has found that it is one
of the predictor factors for BCS and MTX þ R. “Never
married” was a significant determinant for BCS, whereas
women who were divorced or widowed were more likely to
have MTX þ R compared to those who had MTX alone.
In Hong Kong, there is no population-based breast
cancer screening; women can only access screening ser-
vice in private sector. Our study also shows that
mammography screening, screen-detected tumor, and
smaller tumor size were associated with increased likeli-
hood of BCS, a finding in line with previous studies that
suggested breast cancer screening increases the rate of
BCS.26e28 Breast cancer screening not only savesPlease cite this article in press as: Chan SWW, et al., Surgical options fo
Hong Kong Breast Cancer Registry, Asian Journal of Surgery (2016), htlives,29e35 but also retains breasts for cosmetic reasons,
which improves the psychosocial being and quality of life
of breast cancer patients. The HKBCF has long been an
advocate of a population-wide mammography screening
program in Hong Kong where such an initiative is yet to be
in place. Our data show the benefits of breast screening
and should be taken into account in the drawing up of
local breast screening policy.
Meanwhile, the rate of breast conservation has been
found to be lower in patients with centrally located tumor
and larger tumor. These factors seem intrinsic, but with
medical advances in oncoplastic surgery36e39 and neo-
adjuvant chemotherapy,40 it helped to extend BCS indica-
tion. Tumors considered too large or that are situated in an
unfavorable location for breast conservation therapy should
be evaluated with input from both the oncologists and
surgeons with oncoplastic training. Education and training
in techniques extending BCS indication as well as in various
breast reconstruction options should enable surgeons to
offer personalized surgical options for breast cancer
patients.
It is noteworthy that more patients in private medical
facilities underwent BCS compared with public medical
facilities. In Hong Kong, all patients have free medical
coverage by government including all surgical procedures in
public hospitals. In this context, financial cost is unlikely
affecting the choice of surgical options. Is the difference
attributed to surgeon belief, the surgeon’s technique, re-
sources implication, or worry of re-excision? Based on the
scientific clinical evidence published by the National
Guideline Clearinghouse and the National Collaborating
Centre for Cancer, surgical management of early-stage
breast cancer and ductal carcinoma in situ for eligible
candidates should be based on patient’s preference, not
the surgeon’s preference.41,42 However, patient preference
may be affected by culture and informed consent process.
Further studies are appreciated to delineate how these
factors interact with the informed consent process and
surgical choices.
Our study is the first study using more than 4000 pa-
tients’ data extracted from the HKBCR to investigate the
factors associated with surgical treatments for Chinese
breast cancer patients in Hong Kong. However, our study is
a study of retrospective data retrieval only. It does not
include physician difference and it cannot capture data on
patient’s own decision factors.
In conclusion, this study has shown that patient-related
factors such as age, education, marital status, mammog-
raphy screening, the use of private medical facilities, and
clinical characteristics including smaller tumor size and
peripherally located tumor, were significant predictors for
type of surgical treatments in Chinese women with early
breast cancer. More works are to be done on patient edu-
cation, surgical training, for example, neoadjuvant
chemotherapy and oncoplastic surgery techniques, which
increase surgical options for breast cancer patients. By
promoting these aspects, we believe surgeons and patients
themselves could make better surgical decisions for their
surgical treatment of breast cancer.r Chinese patients with early invasive breast cancer: Data from the
tp://dx.doi.org/10.1016/j.asjsur.2016.02.003
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